Back to search

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.

Data up to Jan 2025

Published1992
Citations378
References26

Total Citations Per Year

Abstract

References (26)

The Pathogenesis of Atherosclerosis — An Update

1986 • 4,951 citations

Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications

1988 • 2,527 citations

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

1991 • 1,161 citations

Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking

1986 • 1,154 citations

Advanced Glycosylation End Products in Patients with Diabetic Nephropathy

1991 • 925 citations

Hypothesis: Vasa Vasorum and Neovascularization of Human Coronary Arteries

1984 • 852 citations

Accelerated age-related browning of human collagen in diabetes mellitus.

1984 • 671 citations

Cachectin/TNF and IL-1 Induced by Glucose-Modified Proteins: Role in Normal Tissue Remodeling

1988 • 606 citations

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy.

1991 • 522 citations

Immunochemical detection of advanced glycosylation end products in vivo.

1992 • 496 citations

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.

1990 • 478 citations

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.

1989 • 383 citations

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

1990 • 370 citations

Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.

1992 • 353 citations

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.

1992 • 261 citations

Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.

1992 • 218 citations

Post-Translational Modifications of Proteins

1993 • 217 citations

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.

1991 • 210 citations

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.

1991 • 189 citations

Replacement of Renal Function by Dialysis

1979 • 160 citations

Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes.

1983 • 157 citations

Increased Vascular Permeability in Spontaneously Diabetic BB/W Rats and in Rats With Mild Versus Severe Streptozocin-Induced Diabetes: Prevention by Aldose Reductase Inhibitors and Castration

1987 • 156 citations

Endothelium-Dependent Relaxation in Aorta of BB Rat

1987 • 151 citations

Sensitivity of various visualization methods for peroxidase and alkaline phosphatase activity in immunoenzyme histochemistry

1985 • 105 citations

Albumin Permeation of New Vessels Is Increased in Diabetic Rats

1985 • 43 citations

Hyperglycemia, diabetes and vascular disease

1993 • 19 citations

Cited By (0)

Loading...
Exogenous advanced glycosylation end products induce complex vascular dysfunction in… (1992) – Proceedings of the National Academy of Sciences | Metascience Observatory Explorer